MedTrace Logo

Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"

NCT03727139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1021

Last updated 2024-03-08

Study results available
· View outcomes & findings →

Summary

The purpose of this survey is to evaluate the long-term safety of Rasagiline (AZILECT) in patients with Parkinson's disease in daily clinical practice and also collect efficacy information.

Conditions

Interventions

DRUG

Rasagiline

Rasagiline Tablets

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03727139 on ClinicalTrials.gov